PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A case of papilledema completely regressed after 3 months of treatment with Dashamoola and Punarnavashtaka Kwatha, with no recurrence reported for over 3 years [PMID:27011720].
Complete remission was observed in a patient after four months of treatment involving Dashamoola katutraya kashaya among other Ayurvedic therapies [PMID:28302414].
Dashamoola Taila Matra Basti was evaluated for its Vatashamaka, Yonishula Prashaman, and Shothahara properties in patients aged 15-25 years [PMID:22131731].
A patient was managed with a combination of Ayurvedic medicines including 40 ml Dashamoola Kwatha and other procedures [PMID:34961685].
Dashamoola Kwatha showed 19.9 ± 1.8% inhibition of paw edema in CFA-induced inflammation in rats [PMID:28376870].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36743273 (2021) — A comparative diuretic evaluation of fruit and root of Gokshura (Tribulus terrestris Linn.) in albino rats. · Ayu
- 2.PMID: 27143797 (2016) — Pharmacological potentials of Premna integrifolia L. · Ancient science of life
- 3.PMID: 27011720 (2015) — Ayurvedic management of papilledema. · Ayu
- 4.PMID: 23326090 (2012) — Anti-inflammatory activity of root bark and stem bark of Shyonaka. · Journal of Ayurveda and integrative medicine
- 5.PMID: 28376870 (2017) — Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model. · BMC complementary and alternative medicine